Elizabeth Anderson
Stock Analyst at Evercore ISI Group
(2.36)
# 2,526
Out of 5,163 analysts
144
Total ratings
48.89%
Success rate
-3.07%
Average return
Main Sectors:
Stocks Rated by Elizabeth Anderson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| XRAY DENTSPLY SIRONA | Maintains: In-Line | $12 → $15 | $11.54 | +29.98% | 9 | Feb 27, 2026 | |
| TDOC Teladoc Health | Maintains: In-Line | $8 → $5 | $5.37 | -6.89% | 7 | Feb 26, 2026 | |
| MDLN Medline | Maintains: Outperform | $50 → $55 | $41.46 | +32.66% | 2 | Feb 26, 2026 | |
| HSIC Henry Schein | Maintains: Outperform | $90 → $100 | $75.57 | +32.33% | 3 | Feb 25, 2026 | |
| WAY Waystar Holding | Maintains: Outperform | $40 → $27 | $24.16 | +11.75% | 5 | Feb 18, 2026 | |
| HNGE Hinge Health | Maintains: Outperform | $65 → $50 | $45.00 | +11.11% | 3 | Feb 11, 2026 | |
| DGX Quest Diagnostics | Maintains: In-Line | $190 → $220 | $199.70 | +10.17% | 5 | Feb 11, 2026 | |
| ALGN Align Technology | Maintains: Outperform | $180 → $200 | $164.23 | +21.78% | 16 | Feb 5, 2026 | |
| FTRE Fortrea Holdings | Upgrades: Outperform | $14 → $25 | $8.94 | +179.64% | 11 | Jan 6, 2026 | |
| PRVA Privia Health Group | Maintains: Outperform | $28 → $30 | $21.68 | +38.38% | 5 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $28 | $14.53 | +92.70% | 1 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $81 → $70 | $24.37 | +187.24% | 10 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $220 | $217.08 | +1.35% | 10 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $85 → $95 | $76.13 | +24.79% | 10 | Oct 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $220 → $240 | $164.72 | +45.70% | 7 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $4 → $3 | $1.32 | +127.27% | 9 | Oct 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $305 | $263.80 | +15.62% | 7 | Oct 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $800 → $825 | $940.91 | -12.32% | 7 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $19 → $23 | $24.61 | -6.54% | 4 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $5 → $3 | $0.60 | +400.00% | 5 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: In-Line | $68 → $26 | $1.59 | +1,550.94% | 3 | Mar 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $35 → $15 | $1.56 | +861.54% | 3 | Mar 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: In-Line | $11 | $0.65 | +1,591.79% | 2 | Jan 4, 2022 |
DENTSPLY SIRONA
Feb 27, 2026
Maintains: In-Line
Price Target: $12 → $15
Current: $11.54
Upside: +29.98%
Teladoc Health
Feb 26, 2026
Maintains: In-Line
Price Target: $8 → $5
Current: $5.37
Upside: -6.89%
Medline
Feb 26, 2026
Maintains: Outperform
Price Target: $50 → $55
Current: $41.46
Upside: +32.66%
Henry Schein
Feb 25, 2026
Maintains: Outperform
Price Target: $90 → $100
Current: $75.57
Upside: +32.33%
Waystar Holding
Feb 18, 2026
Maintains: Outperform
Price Target: $40 → $27
Current: $24.16
Upside: +11.75%
Hinge Health
Feb 11, 2026
Maintains: Outperform
Price Target: $65 → $50
Current: $45.00
Upside: +11.11%
Quest Diagnostics
Feb 11, 2026
Maintains: In-Line
Price Target: $190 → $220
Current: $199.70
Upside: +10.17%
Align Technology
Feb 5, 2026
Maintains: Outperform
Price Target: $180 → $200
Current: $164.23
Upside: +21.78%
Fortrea Holdings
Jan 6, 2026
Upgrades: Outperform
Price Target: $14 → $25
Current: $8.94
Upside: +179.64%
Privia Health Group
Nov 7, 2025
Maintains: Outperform
Price Target: $28 → $30
Current: $21.68
Upside: +38.38%
Nov 7, 2025
Maintains: Outperform
Price Target: $27 → $28
Current: $14.53
Upside: +92.70%
Nov 7, 2025
Maintains: Outperform
Price Target: $81 → $70
Current: $24.37
Upside: +187.24%
Oct 31, 2025
Maintains: Outperform
Price Target: $190 → $220
Current: $217.08
Upside: +1.35%
Oct 30, 2025
Maintains: Outperform
Price Target: $85 → $95
Current: $76.13
Upside: +24.79%
Oct 8, 2025
Maintains: Outperform
Price Target: $220 → $240
Current: $164.72
Upside: +45.70%
Oct 8, 2025
Maintains: In-Line
Price Target: $4 → $3
Current: $1.32
Upside: +127.27%
Oct 3, 2025
Maintains: Outperform
Price Target: $300 → $305
Current: $263.80
Upside: +15.62%
Sep 24, 2025
Maintains: Outperform
Price Target: $800 → $825
Current: $940.91
Upside: -12.32%
Jul 9, 2025
Maintains: Outperform
Price Target: $19 → $23
Current: $24.61
Upside: -6.54%
Jul 9, 2025
Maintains: In-Line
Price Target: $5 → $3
Current: $0.60
Upside: +400.00%
Mar 16, 2022
Maintains: In-Line
Price Target: $68 → $26
Current: $1.59
Upside: +1,550.94%
Mar 2, 2022
Downgrades: In-Line
Price Target: $35 → $15
Current: $1.56
Upside: +861.54%
Jan 4, 2022
Downgrades: In-Line
Price Target: $11
Current: $0.65
Upside: +1,591.79%